What's Going On With Pfizer Shares Tuesday?
Portfolio Pulse from Dylan Berman
Pfizer, Inc. (NYSE:PFE) shares are slightly up after the company reported positive top-line results for its ABRYSVO vaccine for RSV in immunocompromised adults. The Phase 3 MONeT trial showed strong neutralizing responses and a good safety profile.
August 13, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Pfizer shares are up 1.32% following positive results from the Phase 3 MONeT trial of its ABRYSVO vaccine for RSV in immunocompromised adults. The vaccine showed strong neutralizing responses and a good safety profile.
The positive trial results for ABRYSVO, a novel RSV vaccine, indicate strong efficacy and safety, which is likely to boost investor confidence and drive short-term stock price gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100